학술논문

A randomised phase III multicentre trial to evaluate the duration of anti-PD1 monoclonal antibody monotherapy in patients with metastatic melanoma (DANTE) - Stage 1 Results
Document Type
Journal
Source
BRITISH JOURNAL OF CANCER; OCT 4 2019, 121 p23-p23, 1p. Supplement: S
Subject
Language
English
ISSN
15321827